OakChart

Definium Therapeutics Inc

DFTXHealthcare·Biotechnology·USA·Mid·NASD·Nov 13 • 7:36 AM ET

32.93-0.07 (-0.22%)
2026-11-13 13:45 CET
Market cap
$4.51B
Revenue, TTM
0.00 USD m
Net income, TTM
-337.48 USD m
Free cash flow, TTM
-188.74 USD m
EPS diluted, TTM
-3.03
Price / earnings
-
Compare

Price

DFTX against its 20, 50 and 200-day averages
Terms2050200BeatMiss
Patternshover a marker to name it
RS 70Sales 0.00Price0.0020.0030.0040.0050.0010.1M20.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DFTXclose 32.9320-day 34.6550-day 36.09200-day 30.4332.9352w high 49.7052-week range, not 6 months

33.8% under the 52-week high of 49.70 on 7 Aug 2026. 52-week low 10.47 on 21 Nov 2025. Last 15 sessions, 29.7% high to low

Volume 0.01× normal · the line is the 50-bar volume average

Setup. RS line 70
CANSLIM 4 of 6 — fails: EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High
VCP 5 of 6 — fails: 52-Week High/Low: 0-10% below High
Minervini 3 of 4 — fails: 52-Week High/Low: 0-10% below High
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 3 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50
Growth 2 of 4 — fails: EPS Growth This Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15% — not on the tape: Net Profit Margin: High (>20%); P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2; Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 3 of 4 — fails: Float: Under 100M
Accumulation 4 of 4
Relative Strength 3 of 3

Profile

DFTX
52-week range, 57% of the way up
10.4749.70

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

IndexRUT
Employees106
IPONov 15, 2016
Beta2.22
ATR, 14d1.94
Rel volume0.01
Short float7.43%
Insider own5.49%
Inst own86.91%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$4.51B
Enterprise Value3.50B
Income-337.48M
Sales0.00M
Book / share7.07
Cash / share7.65
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees106
IPONov 15, 2016

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales-
Price / book4.66
Price / cash4.31
Price / free cash flow-
Value / cash profit-
Value / sales-
Quick Ratio15.53
Current Ratio15.53
Debt / equity0.04
Long-term debt / equity0.04
Options and shortYes / Yes

Earnings

Earnings / share-3.03
Earnings next year-1.98
Earnings next quarter-0.50
Earnings this year-45.77%
Earnings next year34.02%
Earnings growth, 5 years25.70%
Past earnings growth-3.78% -1.48%
Past sales growth- -
Earnings vs last year-53.65%
Sales vs last year-
Earnings vs last quarter52.13%
Sales vs last quarter-
EarningsNov 09 AMC
Surprise34.27% -

Ownership

Insiders own5.49%
Insider trades-1.83%
Institutions own86.91%
Institution trades34.96%
Return on assets-51.48%
Return on equity-61.44%
Return on capital-33.59%
Gross Margin-
Operating margin-
Profit Margin-
20-day average-4.98%
50-day average-8.76%
200-day average8.19%

Technical

Shares out136.89M
Shares floating129.38M
Short / float7.43%
Short ratio4.80
Short interest9.61M
52-week high49.70 -33.8%
52-week low10.47 +214.6%
Volatility5.74% 5.78%
Average range1.94
Strength index43.70
Market sensitivity2.22
Relative volume0.01
Avg Volume2.00M
Volume709

Performance

Perf Week-1.03%
Perf Month-3.89%
Perf Quarter-27.25%
Perf Half Y56.87%
Perf YTD145.90%
Perf Year183.11%
Perf 3Y1254.98%
Perf 5Y-8.16%
Perf 10Y-
Recommendation1.05
Target Price72.78
Prev Close33.00
Price32.93
Change %-0.22%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 09, 2026InitiatedJP MorganOverweight$84+155.1%
Aug 18, 2026InitiatedBofA SecuritiesBuy$75+127.8%
Jul 27, 2026InitiatedWells FargoOverweight$68+106.5%
Jun 23, 2026ReiteratedNeedhamBuy$38 → $50+51.9%
Apr 17, 2026InitiatedStifelBuy$30-8.9%
Apr 10, 2026InitiatedPiper SandlerOverweight$49+48.8%
Feb 24, 2026InitiatedWolfe ResearchOutperform$25-24.1%
Jan 30, 2026InitiatedJefferiesBuy$30-8.9%
Oct 13, 2025InitiatedNeedhamBuy$28-15.0%
Aug 04, 2025ResumedOppenheimerOutperform$25-24.1%

Peers

Mkt cap
TickerCompanyMkt cap
GHRSGH Research PLC1.27B
HELPHelus Pharma Inc661.16M
CMPSCompass Pathways Plc ADR1.30B
AXSMAxsome Therapeutics Inc7.59B
ANROAlto Neuroscience Inc1.23B
SPTXSeaport Therapeutics Inc1.08B
ACADAcadia Pharmaceuticals Inc3.13B
DRUGBright Minds Biosciences Inc224.31M
LBRXLB Pharmaceuticals Inc1.37B
NBIXNeurocrine Biosciences Inc17.31B

Insider trading

latest 14 of 36
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Karlin DanielChief Medical OfficerSep 25 '26Sale36.5710,853396,894792,846Sep 29 09:15 PM
Barrow RobertChief Executive OfficerSep 25 '26Sale36.5731,5501,153,7842,213,090Sep 29 09:14 PM
Wiley Matthew T.Chief Commercial OfficerSep 25 '26Sale36.573,097113,257359,036Sep 29 09:12 PM
Sullivan MarkChief Legal OfficerSep 25 '26Sale36.5714,051513,845494,228Sep 29 09:10 PM
Roberts BrandiChief Financial OfficerSep 25 '26Sale36.573,377123,497394,528Sep 29 09:08 PM
MARK SULLIVANOfficerSep 25 '26Proposed Sale36.7314,051516,093Sep 25 04:19 PM
BRANDI ROBERTSOfficerSep 25 '26Proposed Sale36.733,377124,037Sep 25 04:15 PM
MATTHEW THOMAS WILEYOfficerSep 25 '26Proposed Sale36.733,097113,753Sep 25 04:14 PM
DANIEL ROLLINGS KARLINOfficerSep 25 '26Proposed Sale36.7310,853398,631Sep 25 04:08 PM
ROBERT B BARROWOfficerSep 25 '26Proposed Sale36.7331,5501,158,832Sep 25 04:06 PM
Vallone Carol ADirectorSep 18 '26Option Exercise35.521,08638,57522,296Sep 18 09:55 PM
Krebs AndreasDirectorSep 18 '26Option Exercise35.521,62957,86221,402Sep 18 09:55 PM
Barrow RobertChief Executive OfficerSep 03 '26Sale37.9419,023721,7331,494,640Sep 04 09:30 PM
ROBERT B BARROWOfficerSep 03 '26Proposed Sale37.7519,023718,145Sep 03 04:28 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.86B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWOiShares Russell 2000 Growth ETFAUM: 14.25B
IBBiShares Biotechnology ETFAUM: 11.39B
VTWOVanguard Russell 2000 Index ETFAUM: 16.90B
SCHASchwab U.S. Small-Cap ETFAUM: 22.44B
IHEiShares U.S. Pharmaceuticals ETFAUM: 1.73B
VHTVanguard Health Care ETFAUM: 21.54B
CGMMCapital Group U.S. Small and Mid Cap ETFAUM: 3.72B
XPHState Street SPDR S&P Pharmaceuticals ETFAUM: 530.07M

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS -0.370 beat -0.563, from -0.780 a year earlier. Sales 0.00 matched 0.00, from 0.00 a year earlier
EPS
0.0000-1.4402024Q4 EPS -0.410 against -0.29324Q42025Q1 EPS -0.270 against -0.36325Q12025Q2 EPS -0.500 against -0.38025Q22025Q3 EPS -0.780 against -0.50125Q32025Q4 EPS -0.510 against -0.48425Q42026Q1 EPS -0.710 against -0.49226Q12026Q2 EPS -1.440 against -0.54126Q22026Q3 EPS -0.370 against -0.56326Q3
Sales, USD millions
0.890-0.892024Q4 sales 0.00 against 0.0024Q42025Q1 sales 0.00 against 0.0025Q12025Q2 sales 0.00 against 0.0025Q22025Q3 sales 0.00 against 0.0025Q32025Q4 sales 0.00 against 0.0025Q42026Q1 sales 0.00 against 0.0026Q12026Q2 sales 0.00 against 0.0026Q22026Q3 sales 0.00 against 0.0026Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-09 16:30-0.370-0.563-0.3700.000.00EPS -34.3% · sales -vs 2025Q3, year-ago quarter · EPS -52.6% · sales -17 EPS · 12 salesOpen -2.66% vs SPY -0.63%. Close -2.12% vs SPY -0.37%
2026Q2ended 2026-06-302026-08-06 16:30-1.440-0.541-1.4360.000.00EPS +166.2% · sales -vs 2025Q2, year-ago quarter · EPS +188.0% · sales -15 EPS · 9 salesOpen +0.35% vs SPY +0.32%. Close 0.00% vs SPY +0.61%
2026Q1ended 2026-03-312026-05-07 16:30-0.710-0.492-0.7090.000.00EPS +44.3% · sales -vs 2025Q1, year-ago quarter · EPS +163.0% · sales -14 EPS · 9 salesOpen -1.47% vs SPY +0.46%. Close -4.96% vs SPY +0.83%
2025Q4ended 2025-12-312026-02-26 16:30-0.510-0.484-0.5110.000.00EPS +5.4% · sales -vs 2024Q4, year-ago quarter · EPS +24.4% · sales -14 EPS · 9 salesOpen -1.62% vs SPY -0.90%. Close +0.93% vs SPY -0.48%
2025Q3ended 2025-09-302025-11-06 16:30-0.780-0.501-0.7830.000.00EPS +55.6% · sales -vs 2024Q3, year-ago quarter · EPS +333.3% · sales -11 EPS · 7 salesOpen -3.35% vs SPY -0.36%. Close +3.17% vs SPY +0.10%
2025Q2ended 2025-06-302025-07-31 16:30-0.500-0.380-0.5010.000.00EPS +31.6% · sales -vs 2024Q2, year-ago quarter · EPS +525.0% · sales -9 EPS · 6 salesOpen -6.38% vs SPY -0.91%. Close -7.15% vs SPY -1.64%
2025Q1ended 2025-03-312025-05-08 08:30-0.270-0.363-0.2750.000.00EPS -25.6% · sales -vs 2024Q1, year-ago quarter · EPS -76.3% · sales -10 EPS · 6 salesOpen -1.21% vs SPY +0.73%. Close -1.97% vs SPY +0.70%
2024Q4ended 2024-12-312025-03-06 08:30-0.410-0.293-0.4140.000.00EPS +39.9% · sales -vs 2023Q4, year-ago quarter · EPS -29.3% · sales -10 EPS · 6 salesOpen -5.02% vs SPY -1.30%. Close +3.61% vs SPY -1.78%
2024Q3ended 2024-09-302024-11-07 16:30-0.180-0.277-0.2750.000.00EPS -35.0% · sales -vs 2023Q3, year-ago quarter · EPS -60.0% · sales -10 EPS · 6 salesOpen +2.26% vs SPY +0.09%. Close +12.90% vs SPY +0.43%
2024Q2ended 2024-06-302024-08-13 08:30-0.080-0.327-0.0810.000.00EPS -75.5% · sales -vs 2023Q2, year-ago quarter · EPS -89.5% · sales -10 EPS · 6 salesOpen +5.11% vs SPY +0.61%. Close -3.80% vs SPY +1.64%
2024Q1ended 2024-03-312024-05-08 16:30-1.140-0.529-1.1370.000.00EPS +115.7% · sales -vs 2023Q1, year-ago quarter · EPS +75.4% · sales -7 EPS · 5 salesOpen -2.91% vs SPY +0.04%. Close -5.10% vs SPY +0.58%
2023Q4ended 2023-12-312024-02-28 08:30-0.580-0.463-0.5920.000.00EPS +25.3% · sales -vs 2022Q4, year-ago quarter · EPS +346.2% · sales -7 EPS · 4 salesOpen -6.12% vs SPY -0.32%. Close -3.78% vs SPY -0.13%
2023Q3ended 2023-09-302023-11-02 16:30-0.450-0.654-0.4510.000.00EPS -31.2% · sales -vs 2022Q3, year-ago quarter · EPS -19.6% · sales -7 EPS · 3 sales-
2023Q2ended 2023-06-302023-08-03 16:30-0.760-0.534-0.7550.000.00EPS +42.4% · sales -vs 2022Q2, year-ago quarter · EPS +26.7% · sales -8 EPS · 4 sales-
2023Q1ended 2023-03-312023-05-04 16:30-0.650-0.422-0.6520.000.00EPS +54.1% · sales -vs 2022Q1, year-ago quarter · EPS +8.3% · sales -6 EPS · 3 sales-
2022Q4ended 2022-12-312023-03-09 08:30-0.130-0.492-0.1290.000.00EPS -73.6% · sales -vs 2021Q4, year-ago quarter · EPS -78.3% · sales -8 EPS · 4 sales-

Annual earnings

2025FY EPS -2.060 missed -2.003, from -1.540 a year earlier. Sales 0.00 missed 1.50, from 0.00 a year earlier
EPS
0.0000-3.5002020FY EPS -1.500 against -1.50020202021FY EPS -3.450 against -3.50020212022FY EPS -1.840 against -2.29620222023FY EPS -2.440 against -2.27420232024FY EPS -1.540 against -1.43220242025FY EPS -2.060 against -2.0032025
Sales, USD millions
1.5002020FY sales 0.00 against 0.0020202021FY sales 0.00 against 0.0020212022FY sales 0.00 against 0.0020222023FY sales 0.00 against 0.0020232024FY sales 0.00 against 0.0020242025FY sales 0.00 against 1.502025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-3.780--1,1688.71
2029FYestimate-1.087--645.1630.28
2028FYestimate--0.845--267.02-
2027FYestimate--1.981--29.35-
2026FYestimate--3.003--0.00-
2025FY-2.060-2.003-2.0600.001.50-
2024FY-1.540-1.432-1.5420.000.00-
2023FY-2.440-2.274-2.4450.000.00-
2022FY-1.840-2.296-1.8410.000.00-
2021FY-3.450-3.500-3.3980.000.00-
2020FY-1.500-1.500-1.9120.000.00-

Quarterly results

2026Q3 revenue 0.00, from 0.00 a year earlier
Revenue, USD millions
0.890-0.892024Q4 revenue 0.0024Q42025Q1 revenue 0.0025Q12025Q2 revenue 0.0025Q22025Q3 revenue 0.0025Q32025Q4 revenue 0.0025Q42026Q1 revenue 0.0026Q12026Q2 revenue 0.0026Q22026Q3 revenue 0.0026Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E -3.00 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-11-3.00-0.6%
2026Q4Eper share2026-11-11-0.50-0.7%
2026FYRper share2026-11-11-3.00-0.6%
2026Q4Rper share2026-11-11-0.50-0.7%
2026Q4Sper share2026-11-100.00-
2026Q3Eper share2026-10-28-0.560.0%
2026Q3Rper share2026-10-28-0.560.0%
2026FYSper share2026-10-160.00-
2026Q3Sper share2026-10-080.00-
2026Q2Eper share2026-07-26-0.540.0%
2026Q2Rper share2026-07-26-0.550.0%
2026Q2Sper share2026-07-240.00-
2026Q1Eper share2026-04-23-0.49+3.1%
2026Q1Rper share2026-04-22-0.47-2.9%
2026Q1Sper share2026-04-210.00-
2025FYEper share2026-02-20-2.00-0.4%
2025Q4Eper share2026-02-20-0.48-2.5%
2025FYSper share2026-02-201.50-
2025Q4Sper share2026-02-200.00-
2025FYRper share2026-01-30-2.01+0.1%
2025Q4Rper share2026-01-30-0.45+0.4%
2025Q3Eper share2025-10-30-0.50+0.1%
2025Q3Rper share2025-10-15-0.500.0%
2025Q3Sper share2025-10-100.00-
2025Q2Eper share2025-07-24-0.37+0.5%
2025Q2Rper share2025-07-24-0.38+2.0%
2025Q2Sper share2025-05-080.00-
2024FYEper share2025-03-06-1.49+4.0%
2024Q4Eper share2025-03-06-0.29+0.1%
2025Q1Eper share2025-03-06-0.36+5.4%
2024FYRper share2025-03-06-1.57+9.3%
2024Q4Rper share2025-03-06-0.33+1.6%
2025Q1Rper share2025-03-06-0.36+3.6%
2024FYSper share2025-03-060.00-
2024Q4Sper share2025-03-060.00-
2025Q1Sper share2025-03-060.00-
2024Q3Eper share2024-10-28-0.280.0%
2024Q3Rper share2024-10-28-0.310.0%
2024Q3Sper share2024-08-130.00-
2024Q2Eper share2024-08-10-0.330.0%
2024Q2Rper share2024-08-10-0.310.0%
2024Q2Sper share2024-07-230.00-
2024Q1Eper share2024-04-12-0.53+25.9%
2024Q1Sper share2024-04-120.00-
2024Q1Rper share2024-03-20-0.450.0%
2023FYEper share2024-01-24-2.270.0%
2023FYRper share2024-01-24-2.250.0%
2023FYSper share2023-12-040.00-

Estimate history

Annual
Metric201620172018202020212022202320242025TTMMRQ
EPS per share-1.809-4.853-2.746-1.912-3.398-1.841-2.445-1.542-2.058-3.0306-
Sales USD millions0000000000-
Shares million shares000242838417599-137
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share-0.275-0.414-0.275-0.501-0.783-0.511-0.709-1.436-0.375
Sales USD millions000000000
Shares million shares827576767799104134137

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202018FY8/31/2018
Total Revenue0.000.000.000.000.000.000.00-0.00
Cost of Goods Sold Incl. D&A0.000.00-100.0%0.53-83.2%3.16-1.9%3.22+22.9%2.620.00-0.01
Gross Profit0.000.00-0.53-3.16-3.22-2.620.00--0.01
Selling, General and Administrative Excl. Other254.15166.31+60.9%103.39+14.0%90.70+43.7%63.11-30.6%90.94+175.3%33.03-0.86
Research and Development169.81117.67+81.7%64.77+32.3%48.96+48.4%32.99+2.5%32.17+72.7%18.63--
Other Operating Expense0.000.000.000.000.000.000.00-0.00
Operating Income-254.15-166.31-103.92-93.87-66.33-93.55-33.03--0.86
Interest Expense4.905.48+140.4%2.28-0.00-100.0%0.36+125.0%0.16-0.00
Unusual Expense98.9822.83+70.4%13.40+101.8%6.64-7.84-2713.3%0.30-65.5%0.87--
Net Income Before Taxes-337.48-183.79-108.68-95.73-56.80-94.19-33.94--0.86
Income Taxes0.000.000.000.000.00-1.160.00-0.00
Consolidated Net Income-337.48-183.79-108.68-95.73-56.80-93.04-33.94--0.86
Net Income From Continuing Operations-337.48-183.79-108.68-95.73-56.80-93.04-33.94--0.86
Net Income-337.48-183.79-108.68-95.73-56.80-93.04-33.94--0.86
EPS (Recurring) per share-1.97-1.88-1.41-2.33-2.02-3.39-1.88--2.75
EPS (Basic, Before Extraordinaries) per share-3.03-2.06-1.54-2.44-1.84-3.40-1.91--2.75
EPS (Diluted) per share-3.03-2.06-1.54-2.44-1.84-3.40-1.91--2.75
EBITDA-254.15-166.31-103.39-90.70-63.11-90.94-33.03--0.86
Non-Operating Income (Expense)20.5510.83-0.8%10.92+128.9%4.77+182.2%1.69+8350.0%0.02-84.6%0.13-0.00
Other After Tax Adjustments0.000.000.000.000.000.000.00-0.00
Stock Option Compensation Expense33.1520.10+18.9%16.91+9.2%15.49+13.0%13.71-56.0%31.18+320.8%7.41-0.15
Shares Outstanding million shares136.8998.78+31.5%75.10+82.7%41.10+8.2%37.98+35.0%28.13+16.8%24.08-0.35
Market Capitalization4,517.704,517.70+1972.5%217.98-25.4%292.240.0%292.24-49.8%582.22-73.6%2,202.92-4.21

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.000.00-100.0%0.00-100.0%
Gross Profit0.000.000.000.000.000.000.000.00
Selling, General and Administrative Excl. Other72.28+58.3%75.08+83.6%59.22+84.1%47.58+46.6%45.67+84.2%40.90+67.2%32.16+48.3%32.46+51.5%
Research and Development46.14+48.9%48.67+63.3%41.48+77.6%33.52+54.0%30.98+80.2%29.81+103.5%23.36+108.9%21.76+102.2%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-72.28-75.08-59.22-47.58-45.67-40.90-32.16-32.46
Interest Expense1.15-9.4%1.23-47.4%1.25+108.3%1.27+92.4%1.27+74.0%2.34+397.9%0.60+39.5%0.66
Unusual Expense-12.35-154.8%86.23+3766.8%20.055.06+4.3%22.552.23-7.00-121.3%4.85+63.3%
Net Income Before Taxes-50.96-158.99-77.10-50.44-67.27-42.74-23.35-34.74
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-50.96-158.99-77.10-50.44-67.27-42.74-23.35-34.74
Net Income From Continuing Operations-50.96-158.99-77.10-50.44-67.27-42.74-23.35-34.74
Net Income-50.96-158.99-77.10-50.44-67.27-42.74-23.35-34.74
EPS (Recurring) per share-0.44-0.89-0.58-0.47-0.60-0.48-0.33-0.37
EPS (Basic, Before Extraordinaries) per share-0.37-1.44-0.71-0.51-0.78-0.50-0.27-0.41
EPS (Diluted) per share-0.37-1.44-0.71-0.51-0.78-0.50-0.27-0.41
EBITDA-72.28-75.08-59.22-47.58-45.67-40.90-32.16-32.46
Non-Operating Income (Expense)10.12+355.9%3.56+30.4%3.41+41.5%3.47+7.4%2.22-36.2%2.73-11.4%2.41+113.3%3.23+146.6%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense10.78+85.2%9.64+83.6%7.13+107.9%5.60+62.3%5.82+54.4%5.25+27.1%3.43-2.8%3.45-6.3%
Shares Outstanding million shares136.89+78.3%134.37+77.3%104.04+37.8%98.78+31.5%76.77-5.9%75.80+5.2%75.51+6.1%75.10+82.7%
Market Capitalization4,517.70+407.2%5,130.51+946.3%1,884.29+764.4%1,011.66+364.1%890.77+308.6%490.34+124.9%217.98-25.4%217.98-25.4%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202018FY8/31/20182017FY8/31/2017
Cash & Short Term Investments411.59+50.4%273.74+174.6%99.70-29.9%142.14+6.4%133.54+66.7%80.09-0.15-91.1%1.69
Short Term Receivables0.000.000.000.000.000.00-0.010.0%0.01
Inventories0.000.000.000.000.000.00-0.000.00
Other Current Assets7.73-1.9%7.88+89.0%4.17+6.6%3.91+6.3%3.68+157.3%1.43-0.04-42.9%0.07
Total Current Assets419.32+48.9%281.62+171.1%103.87-28.9%146.06+6.4%137.22+68.3%81.52-0.20-88.7%1.77
Net Property, Plant & Equipment0.000.000.000.000.000.00-0.06-14.3%0.07
Total Investments and Advances0.000.000.000.000.000.00-0.14+100.0%0.07
Intangible Assets19.920.0%19.92-2.6%20.45-13.4%23.61-11.9%26.790.00-0.000.00
Other Assets0.86+41.0%0.61+177.3%0.22-33.3%0.330.000.00-3.13+47.6%2.12
Total Assets440.10+45.7%302.15+142.6%124.54-26.7%169.99+3.7%164.00+101.2%81.52-3.53-12.4%4.03
Short Term Debt Incl. Current Port. of LT Debt0.000.000.00-100.0%0.070.000.00-0.00-100.0%0.02
Accounts Payable5.35+166.2%2.010.000.000.000.00-0.000.00
Other Current Liabilities61.35+66.5%36.84+14.2%32.25+81.0%17.82+71.2%10.41+245.8%3.01-0.01-83.3%0.06
Total Current Liabilities66.70+71.7%38.85+20.5%32.25+80.3%17.89+71.9%10.41+245.8%3.01-0.01-87.5%0.08
Long Term Debt40.58+85.7%21.85+54.6%14.130.000.000.00-0.000.00
Provision for Risks Charges0.000.000.000.000.000.00-0.000.00
Other Liabilities0.500.00-100.0%0.03-97.5%1.18-38.9%1.93-26.9%2.64-0.000.00
Total Liabilities107.77+77.5%60.70+30.8%46.41+143.2%19.08+54.6%12.34+118.4%5.65-0.01-87.5%0.08
Non-Equity Reserves0.000.000.000.000.000.00-0.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00-0.000.00
Common Equity332.33+37.6%241.45+209.0%78.13-48.2%150.92-0.5%151.66+99.9%75.87-3.52-10.9%3.95
Total Shareholders Equity332.33+37.6%241.45+209.0%78.13-48.2%150.92-0.5%151.66+99.9%75.87-3.52-10.9%3.95
Accumulated Minority Interest0.000.000.000.000.000.00-0.000.00
Total Equity332.33+37.6%241.45+209.0%78.13-48.2%150.92-0.5%151.66+99.9%75.87-3.52-10.9%3.95
Total Liabilities & Stockholders Equity440.10+45.7%302.15+142.6%124.54-26.7%169.99+3.7%164.00+101.2%81.52-3.53-12.4%4.03
Book Value Per Share per share3.36+4.7%3.21+68.9%1.90-52.1%3.97-26.3%5.39+71.1%3.15-10.08-21.4%12.82
Tangible Book Value Per Share per share3.16+7.1%2.95+110.7%1.40-58.2%3.35-24.5%4.44+41.0%3.15-10.08-21.4%12.82
Full-Time Employees people106+43.2%74+29.8%57+18.8%48+17.1%41-18.0%50---
Price to Book Ratio ratio4.672.812.352.353.8426.46-1.203.92
Return on Assets %-49.52-50.94-65.01-34.01-74.53-80.37--22.70-58.00
Return on Equity %-64.06-68.01-83.59-37.54-79.20-86.35--24.18-60.22
Return on Invested Capital %-49.29-41.28-103.76-37.63-61.34-44.73--24.34-31.08
Quick Ratio ratio6.297.253.228.1613.1827.10-24.1422.02
Current Ratio ratio6.297.253.228.1613.1827.10-24.1422.02

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202018FY8/31/2018
Net Income-332.83-183.79-108.68-95.73-56.80-93.04-33.94--0.86
Depreciation-0.00-100.0%0.53-83.2%3.16-1.9%3.22+22.9%2.620.00-0.01
Other Funds (Non Cash)134.0842.80+32.2%32.37+47.7%21.92+203.6%7.22-83.1%42.72+415.9%8.28-0.15
Funds from Operations-198.75-141.00-75.79-70.65-46.36-47.70-25.66--0.70
Extraordinary Item0.000.000.000.000.000.000.00-0.00
Changes in Working Capital10.029.44-3.34-153.2%6.28-3.78-301.1%1.88-8.7%2.06--0.02
Income Taxes Payable------1.160.00--
Cash from Operating Activities-188.74-131.56-79.13-64.37-50.14-45.82-23.60--0.72
Capital Expenditures0.000.000.000.000.000.000.00--1.04
Net Assets From Acquisitions0.000.000.000.000.00-0.300.00--
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.00--
Purchase or Sale of Investments-603.26-151.610.000.000.000.000.00-1.59
Purchase of Investments-792.77-268.360.000.000.000.000.00--0.07
Sale Or Maturity of Investments189.51116.750.000.000.000.000.00-1.66
Other Uses0.000.000.000.000.000.000.00-0.00
Other Sources0.000.000.000.000.000.000.00-0.00
Cash from Investing Activities-603.26-151.610.000.000.00-0.300.00-0.54
Cash Dividends Paid0.000.000.000.000.000.000.00-0.00
Change in Capital Stock1,017.49247.72+1.8%243.38+3064.9%7.69-87.1%59.46-39.8%98.82+2.2%96.70-0.33
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00-0.00
Sale of Common Pref Stock1,017.49247.72+1.8%243.38+3064.9%7.69-87.1%59.46-39.8%98.82+2.2%96.70-0.33
Proceedsfrom Stock Options993.97243.32+3.8%234.39+3012.7%7.53-87.1%58.54-28.5%81.92+14.4%71.60-0.33
Issuance or Reduction of Debt, Net-0.2619.55+98.1%9.87-30.3%14.160.000.000.00--0.02
Change in Long Term Debt-0.2619.55+98.1%9.87-30.3%14.160.000.000.00-0.00
Issuance of Long Term Debt-0.5541.55+321.0%9.87-30.3%14.160.000.000.00-0.00
Reduction of Long Term Debt0.29-22.000.000.000.000.000.00-0.00
Net Financing Active Other Cash Flow0.000.00-0.050.00-0.410.000.00-0.00
Other Financing Activities Uses0.000.00-0.050.00-0.410.000.00-0.00
Cash from Financing Activities1,017.23267.27+5.6%253.20+1058.8%21.85-63.0%59.05-40.2%98.82+2.2%96.70-0.31
Exchange Rate Effect-0.00-0.01-0.03-137.5%0.08-0.31-141.9%0.74+164.3%0.28-0.02
Net Change in Cash225.23-15.90-109.1%174.04-42.44-593.5%8.60-83.9%53.45-27.2%73.39-0.15
Free Cash Flow-188.74-131.56-79.13-64.36-50.14-45.82-23.60--0.72
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00-0.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00-0.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments1,046.85+400.7%1,083.88+492.3%373.42+75.8%411.59+50.4%209.07-29.2%182.99-24.7%212.44-15.8%273.74+174.6%
Short Term Receivables0.000.000.000.000.000.000.000.00
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets4.91-27.6%8.22+33.9%7.14-22.9%7.73-1.9%6.78+66.6%6.14+34.6%9.26+194.9%7.88+89.0%
Total Current Assets1,051.76+387.3%1,092.10+477.4%380.56+71.7%419.32+48.9%215.85-27.9%189.14-23.6%221.70-13.2%281.62+171.1%
Net Property, Plant & Equipment0.000.000.000.000.000.000.000.00
Total Investments and Advances0.000.00-100.0%0.00-100.0%0.000.0054.8633.100.00
Intangible Assets19.920.0%19.920.0%19.920.0%19.920.0%19.920.0%19.920.0%19.920.0%19.92-2.6%
Other Assets2.61+127.0%0.88-24.8%0.81+32.8%0.86+41.0%1.15+134.7%1.17+120.8%0.61+335.7%0.61+177.3%
Total Assets1,074.28+353.4%1,112.90+319.8%401.29+45.8%440.10+45.7%236.92-25.9%265.09-1.1%275.32-0.1%302.15+142.6%
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.000.000.00
Accounts Payable9.28+14.4%6.96+64.9%7.13+214.1%5.35+166.2%8.114.222.272.01
Other Current Liabilities58.45+2.0%150.24+345.3%73.98+162.2%61.35+66.5%57.30+72.2%33.74-19.4%28.21-56.8%36.84+14.2%
Total Current Liabilities67.73+3.5%157.20+314.1%81.11+166.1%66.70+71.7%65.42+96.6%37.96-9.3%30.48-53.3%38.85+20.5%
Long Term Debt36.66-9.2%36.47-11.5%40.77+85.0%40.58+85.7%40.38+66.1%41.19+69.9%22.04+55.3%21.85+54.6%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities1.86+257.7%0.55+1.9%0.560.500.520.540.00-100.0%0.00-100.0%
Total Liabilities106.25-0.1%194.22+143.7%122.44+133.1%107.77+77.5%106.32+84.6%79.69+20.6%52.52-33.9%60.70+30.8%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity968.03+641.2%918.68+395.5%278.85+25.2%332.33+37.6%130.60-50.2%185.40-8.2%222.81+13.6%241.45+209.0%
Total Shareholders Equity968.03+641.2%918.68+395.5%278.85+25.2%332.33+37.6%130.60-50.2%185.40-8.2%222.81+13.6%241.45+209.0%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity968.03+641.2%918.68+395.5%278.85+25.2%332.33+37.6%130.60-50.2%185.40-8.2%222.81+13.6%241.45+209.0%
Total Liabilities & Stockholders Equity1,074.28+353.4%1,112.90+319.8%401.29+45.8%440.10+45.7%236.92-25.9%265.09-1.1%275.32-0.1%302.15+142.6%
Book Value Per Share per share7.07+315.9%6.84+179.2%2.68-9.2%3.36+4.7%1.70-47.0%2.45-12.5%2.95+6.9%3.21+68.9%
Tangible Book Value Per Share per share6.93+381.3%6.69+206.9%2.49-7.4%3.16+7.1%1.44-51.5%2.18-13.8%2.69+8.5%2.95+110.7%
Full-Time Employees people---106+43.2%---74+29.8%
Price to Book Ratio ratio4.6717.555.627.874.822.202.812.81
Return on Assets %-51.48-51.35-70.22-49.52-60.39-42.95-28.18-50.94
Return on Equity %-61.44-64.09-94.70-64.06-85.59-59.11-37.07-68.01
Return on Invested Capital %-5.07-16.65-24.12-13.53-39.34-18.86-9.54-13.19
Quick Ratio ratio15.536.954.696.293.304.987.277.25
Current Ratio ratio15.536.954.696.293.304.987.277.25

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income-49.07-157.89-77.10-48.77-68.15-43.91-23.35-32.72
Depreciation---0.000.000.000.00-100.0%-0.01-101.3%
Other Funds (Non Cash)-5.63-118.7%99.32+1855.1%29.0211.36+25.9%30.055.08-3.61-109.5%9.02+49.1%
Funds from Operations-54.70-58.56-48.08-37.41-38.09-38.83-26.96-23.71
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital2.82-65.7%6.23-23.9%5.45-4.488.21+729.3%8.19-2.46-0.17
Cash from Operating Activities-51.88-52.33-42.63-41.89-29.89-30.64-29.42-23.88
Capital Expenditures0.000.000.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-367.33-2381.6%-315.4642.0037.5316.10-43.10-162.460.00
Purchase of Investments-436.14-354.080.00-2.55-26.47-77.44-162.460.00
Sale Or Maturity of Investments68.81+61.6%38.62+12.5%42.0040.0842.5734.340.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-367.33-2381.6%-315.4642.0037.5316.10-43.10-162.460.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock7.12+836.8%758.70+632150.0%5.31+431.0%246.360.76-98.9%0.121.00-99.4%-0.53-120.8%
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock7.12+836.8%758.70+632150.0%5.31+431.0%246.360.76-98.9%0.121.00-99.4%-0.53-120.8%
Proceedsfrom Stock Options-3.76-669.7%751.22+7512100.0%4.11+433.8%242.400.66-99.1%0.010.77-99.5%-8.66-446.4%
Issuance or Reduction of Debt, Net0.000.00-100.0%0.00-0.26-0.04-200.0%19.90+103.1%0.00-0.18
Change in Long Term Debt0.000.00-100.0%0.00-0.26-0.04-200.0%19.90+103.1%0.00-0.18
Issuance of Long Term Debt0.000.00-100.0%0.00-0.55-0.09-325.0%42.29+331.5%0.00-0.18
Reduction of Long Term Debt0.00-100.0%0.000.000.290.05-22.390.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities7.12+902.8%758.70+3691.6%5.31+431.0%246.100.71-99.0%20.01+109.7%1.00-99.4%-0.70-130.0%
Exchange Rate Effect-0.00-0.00-100.0%0.000.00-0.020.03-0.010.00
Net Change in Cash-412.10390.904.68241.74-13.09-124.9%-53.70-190.89-225.1%-24.58
Free Cash Flow-51.88-52.33-42.63-41.89-29.89-30.64-29.42-23.88

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.57%9.6M127.0M2.15M
2026-10-157.91%10.0M127.0M2.14M
2026-09-308.94%11.3M126.9M2.17M
2026-09-159.29%11.8M126.8M2.96M
2026-08-317.67%9.8M128.2M2.96M
2026-08-147.00%9.0M128.2M2.98M
2026-07-318.34%10.7M128.9M2.77M
2026-07-158.44%10.6M126.1M2.92M
2026-06-3011.51%14.5M126.1M2.81M
2026-06-1510.27%10.6M103.6M1.91M
2026-05-298.99%9.4M104.9M1.82M
2026-05-158.87%9.2M104.3M1.74M
2026-04-308.90%9.4M105.1M1.75M
2026-04-1510.22%9.8M96.1M1.73M
2026-03-3116.03%15.1M94.4M1.82M
2026-03-1315.91%15.0M94.4M1.91M
2026-02-2720.50%19.3M94.4M1.86M
2026-02-1320.93%19.5M93.2M1.88M
2026-01-3018.62%17.7M94.9M2.04M
2026-01-1522.92%16.8M73.4M2.01M

Option chain

Expiry 2026-11-20 · underlying 32.93, quoted 13 Nov 07:36 ET · ATM 33.00

Option quotes 12 Nov 15:55 ET. A date on a row is older than the last session (12 Nov). 35 rows.

Implied move 11.08% into expiry (call 1.925 + put 1.725 = 3.650 on 32.93)

Put/call open interest 0.76 (5,423 puts / 7,165 calls) · Put/call volume 0.63 (29 puts / 46 calls)

IV change is points against the prior close.

TypeStrikeMoneyBidAskLastChgIVOpen intVolumeLast sizeDeltaThetaVega
call 1 Jan24.00ITM7.7011.500.000.00363.4% +149.80000.880-0.1340.010
put 1 JanOTM0.000.700.000.00213.6% 0.0000-0.120-0.1310.010
call 6 Nov25.00ITM6.8010.507.460.00336.0% +137.31000.865-0.1350.011
put 9 NovOTM0.000.850.310.00198.7% 0.010100-0.135-0.1330.011
call 1 Jan26.00ITM5.609.500.000.00309.3% +130.20000.852-0.1300.011
put 9 NovOTM0.000.800.100.00179.0% 0.012100-0.148-0.1270.011
call 1 Jan27.00ITM5.607.400.000.00207.9% +52.40000.841-0.1190.012
put 9 NovOTM0.000.900.350.00159.8% 0.025800-0.164-0.1210.012
call 9 Nov28.00ITM4.107.507.000.00251.3% +110.50000.817-0.1180.013
put 9 NovOTM0.001.300.430.00140.8% 0.013100-0.183-0.1140.013
call 28 Oct29.00ITM3.106.508.600.00232.4% +110.54000.793-0.1100.014
put 10 NovOTM0.000.800.300.00121.9% 0.03800-0.207-0.1070.014
call 9 Nov30.00ITM2.305.805.500.00224.6% +116.680000.754-0.1070.015
putOTM0.200.750.55+0.17102.9% -5.04,067141-0.246-0.1040.015
call 6 Nov31.00ITM1.955.502.550.00237.3% +95.62000.659-0.1620.018
putOTM0.301.450.90-0.15118.8% -22.94033-0.341-0.1590.018
call 1 Jan32.00ITM1.454.900.000.00231.1% +88.70000.601-0.1720.019
putOTM0.651.351.07+0.0795.8% -46.63851-0.399-0.1680.019
call33.00ATM1.452.401.99+0.39123.9% +1.931110100.538-0.1510.019
put 9 NovATM1.152.301.400.00120.2% -1.810800-0.462-0.1480.019
call34.00OTM0.852.452.200.00146.4% +9.5127110.482-0.1700.019
put 10 NovITM1.702.851.680.00119.4% -17.515400-0.518-0.1660.019
call35.00OTM0.602.651.05-0.60166.2% +3.92,871210.450-0.2000.019
putITM2.304.002.56+0.16146.8% -15.421963-0.550-0.1960.019
call36.00OTM0.301.201.00-0.32119.2% -2.0312420.346-0.1390.018
putITM3.004.904.04-2.31159.2% +38.02911-0.654-0.1350.018
call37.00OTM0.351.000.77-0.98122.5% 0.01,685620.294-0.1310.017
put 5 NovITM2.356.107.100.00186.2% +63.75900-0.706-0.1270.017
call38.00OTM0.400.600.49-0.26109.7% 0.0148710.214-0.0990.014
put 5 NovITM3.307.007.700.00195.8% +86.12300-0.786-0.0950.014
call 10 Nov39.00OTM0.254.900.600.00121.4% 0.081000.199-0.1050.013
put 5 NovITM4.208.007.580.00209.9% +88.5400-0.801-0.1010.013
call40.00OTM0.050.350.25-0.15111.4% 0.04211210.137-0.0760.011
put 21 OctITM5.608.804.950.00194.1% +82.82800-0.863-0.0720.011
call 10 Nov41.00OTM0.000.300.600.00115.9% 0.039000.117-0.0710.010
put 1 JanITM6.008.500.000.00137.6% +21.7000-0.883-0.0660.010
call42.00OTM0.050.250.17-0.08119.2% 0.0518110.099-0.0640.008
put 8 OctITM6.7010.308.170.00205.2% +86.0500-0.901-0.0600.008
call 10 Nov43.00OTM0.000.200.180.00121.0% 0.0107000.081-0.0560.007
put 20 OctITM7.5011.508.600.00228.7% +107.7000-0.919-0.0510.007
call44.00OTM0.000.250.12-0.23135.5% 0.021220.089-0.0680.008
put 20 OctITM8.5012.509.800.00239.2% +110.5000-0.923-0.0530.007
call 9 Nov45.00OTM0.000.200.250.00136.2% 0.0213000.073-0.0590.007
put 1 JanITM9.5012.600.000.00183.5% +47.4000-0.927-0.0540.007
call46.00OTM0.000.200.05-0.05143.4% 0.037110.071-0.0600.007
put 1 JanITM11.0013.600.000.00192.1% +48.7000-0.929-0.0550.007
call 1 Jan47.00OTM0.000.550.000.00150.3% 0.00000.068-0.0610.006
put 1 JanITM12.0014.800.000.00217.4% +67.1000-0.932-0.0560.006
call 9 Nov50.00OTM0.000.400.060.00170.0% 0.0187000.062-0.0640.006
put 1 JanITM15.0018.800.000.00314.2% +144.2000-0.938-0.0590.006

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-05SCHEDULE 13GSEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-18SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-18SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-148-KCurrent report2026-09-14SEC
2026-09-088-KCurrent report2026-09-08SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-03144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-12SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09003.02M6
2026-080000
2026-070000
2026-06002.62M5
2026-050000
2026-040000
2026-0300797.00K3
2026-020000
2026-010000
2025-1200560.94K3
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.10.30%
FMR LLC6.76%
Avoro Capital Advisors LLC6.59%
DRIEHAUS CAPITAL MANAGEMENT LLC6.28%
Capital World Investors6.14%
Jupiter Topco LLC5.15%
PRICE T ROWE ASSOCIATES INC /MD/4.27%
GEODE CAPITAL MANAGEMENT, LLC2.71%
Octagon Capital Advisors LP2.70%
WELLINGTON MANAGEMENT GROUP LLP2.70%

Funds

Fund% owned
SMALLCAP World Fund Inc7.05%
iShares Russell 2000 ETF3.07%
Multi-Manager Directional Alternative Strategies Fund1.58%
VANGUARD EXTENDED MARKET INDEX FUND1.36%
T. Rowe Price Health Sciences Fund, Inc.1.18%
iShares Russell 2000 Growth ETF1.09%
Fidelity Small Cap Index Fund1.07%
T. Rowe Price New Horizons Fund, Inc.1.05%
iShares Biotechnology ETF0.68%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund0.67%

OakChart. DFTX. Cached 15 minutes. Terms